Celltrion
068270.KS
#754
Rank
NZ$45.04 B
Marketcap
$217.49
Share price
0.72%
Change (1 day)
6.46%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Net assets

Net assets on the balance sheet as of June 2024 : NZ$20.61 Billion

According to Celltrion 's latest financial reports the company has NZ$20.61 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Celltrion - Net assets on balance sheet (from 2007 to 2024)

Net assets by year

Year Net assets Change
2022-12-31$NZ$5.33 B7.13%
2021-12-31$NZ$4.98 B13.98%
2020-12-31$NZ$4.37 B18.53%
2019-12-31$NZ$3.68 B6.44%
2018-12-31$NZ$3.46 B8.86%
2017-12-31$NZ$3.18 B29%
2016-12-31$NZ$2.46 B16.61%
2015-12-31$NZ$2.11 B34.77%
2014-12-31$NZ$1.57 B25.16%
2013-12-31$NZ$1.25 B2.04%
2012-12-31$NZ$1.22 B23.7%
2011-12-31$NZ$0.99 B10.84%
2010-12-31$NZ$0.89 B162.49%
2009-12-31$NZ$0.34 B12.1%
2008-12-31$NZ$0.30 B713.38%
2007-12-31$NZ$37.47 M